Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 43.46M P/E - EPS this Y - Ern Qtrly Grth -
Income -4.05M Forward P/E -51.00 EPS next Y - 50D Avg Chg 6.00%
Sales 23.22M PEG - EPS past 5Y 53.90% 200D Avg Chg -8.00%
Dividend N/A Price/Book 1.54 EPS next 5Y - 52W High Chg -42.00%
Recommedations 2.00 Quick Ratio 0.72 Shares Outstanding 7.83M 52W Low Chg 32.00%
Insider Own 39.52% ROA -4.87% Shares Float 4.71M Beta 0.57
Inst Own 14.70% ROE -16.10% Shares Shorted/Prior 8.51K/2.47K Price 5.61
Gross Margin 28.32% Profit Margin -17.44% Avg. Volume 11,946 Target Price -
Oper. Margin -25.34% Earnings Date Nov 11 Volume 13,146 Change 3.89%
About ImmuCell Corporation

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

ImmuCell Corporation News
11/19/24 ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges
11/16/24 ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023)
11/13/24 ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024
11/07/24 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
10/08/24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
08/16/24 ImmuCell Second Quarter 2024 Earnings: US$0.20 loss per share (vs US$0.18 loss in 2Q 2023)
08/13/24 ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
08/07/24 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024
07/09/24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024
06/05/24 ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
06/04/24 ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
05/14/24 ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
05/08/24 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024
04/09/24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
02/29/24 ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript
02/27/24 ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
02/16/24 ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
01/08/24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
ICCC Chatroom

User Image BankingWithLiz Posted - 23 hours ago

$ABVE Top squeeze candidate in to monday ! low float uptrending! $GEVO bio swings $MCRB Long hold $ICCC adding

User Image swingingtech Posted - 5 days ago

$ICCC https://wallstreetwaves.com/immucell-reports-q3-earnings-drop-while-sales-increase-despite-margin-pressures/

User Image raventhemonkey Posted - 1 week ago

$ICCC If RFK Jr is the new head of HHS could be a huge boost for Re-Tain if it ever comes out. Holding......

User Image theRooster007 Posted - 1 week ago

$ICCC additional depth

User Image theRooster007 Posted - 1 week ago

$ICCC

User Image theRooster007 Posted - 1 week ago

$ICCC https://www.stocktitan.net/news/ICCC/immu-cell-announces-unaudited-financial-results-for-the-quarter-gdttzg70ez3f.html#:~:text=ImmuCell%20(ICCC)%20reported%20significant%20growth,month%20sales%20to%20%2423.8%20million.

User Image Thehutchfromkc Posted - 1 week ago

$ICCC I’m seeing -.09 per share which beat expectations

User Image Thehutchfromkc Posted - 1 week ago

$ICCC what were the earnings?

User Image theRooster007 Posted - 1 week ago

$ICCC added 🐔

User Image theRooster007 Posted - 10/30/24

$ICCC 🐔

User Image TommyTwenty Posted - 10/29/24

$ICCC https://youtu.be/n6gSF0L76BA

User Image DonCorleone77 Posted - 1 month ago

$ICCC Immucell reports Q3 revenue $6M, one estimate $5.4M ImmuCell announced preliminary, unaudited sales results for the third quarter of 2024, which ended September 30. During the three-,nine- and twelve-month periods ended September 30 annualized production output was approximately 73%, 81% and 77%, respectively, of the company's estimated full capacity of approximately $30M per year. As of September 30 the backlog of orders aggregated approximately $7.3M. The Company believes that the current backlog reflects strong demand as distributors work to replenish their buffer stocks and as end-users place orders in advance of the first quarter calving season... "We continue to work to achieve FDA approval to commercialize Re-Tain ," commented Michael F. Brigham, President and CEO of ImmuCell. "We plan to provide an update when we have filed our Non-Administrative NADA . We anticipate making this submission later this year, shortly after the inspectional observations at our contract manufacturer are resolved to the satisfaction of the FDA. We have been in discussions with the FDA about an expedited review at that point."

User Image SIGNORAMOUS Posted - 2 months ago

$ICCC I bailed on this in May amid the panic-selling. Patiently waited for due time to pass until the plant can finally be inspected and ReTain approved. I'm back in right now today. The time feels right. Fingers crossed.

User Image intratio Posted - 08/27/24

$ICCC https://www.intratio.com/stock-forecast/ICCC IMMUCELL CORP /DE/ Our statistical model infers the market value of this company will pick up steam in the upcoming days and have solid long-term foundations

User Image TommyTwenty Posted - 08/26/24

$ICCC chairman of the board has been buying a lot lately.

User Image builderup Posted - 08/26/24

Watchlist: $MODD $BRFH $SSKN $KDLY $ICCC

User Image intratio Posted - 3 months ago

$ICCC https://www.intratio.com/stock-forecast/ICCC Our network foretells that this company s value will gain ground during the coming days and will be followed by a positive momentum in the coming months

User Image intratio Posted - 3 months ago

https://www.intratio.com/stock-forecast/ICCC IMMUCELL CORP /DE/ The statistical model judges that the value of this equity has a good setup for the short-term and a significant upward move will come after it in the following months $ICCC

User Image intratio Posted - 3 months ago

$ICCC https://www.intratio.com/stock-forecast/ICCC The automated equity analyst estimates that the stock price of this company will gain momentum in the following days and will have a clear trend of steadily rising market cap

User Image TommyTwenty Posted - 3 months ago

$ICCC http://archive.fast-edgar.com/20240819/AJ2ZU22CLZ22IJ7222ZU2ZY2ECR7Z2224Q66/

User Image Glopolon Posted - 3 months ago

$ICCC 95 shares volume $WYY 8,500 volume $CREX 4,000 volume. Vacation time I guess

User Image Stock_Titan Posted - 3 months ago

$ICCC ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 https://www.stocktitan.net/news/ICCC/immu-cell-announces-unaudited-financial-results-for-the-quarter-dcr8auyrsxda.html

User Image Stock_Titan Posted - 3 months ago

$ICCC ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 https://www.stocktitan.net/news/ICCC/immu-cell-to-announce-unaudited-financial-results-for-the-quarter-p6p277x5cle8.html

User Image NVDAMillionaire Posted - 3 months ago

$ICCC ImmuCell Corporation (NASDAQ:ICCC): Navigating Challenges, Driving Growth http://beyondspx.com/2024/08/01/immucell-corporation-nasdaqiccc-navigating-challenges-driving-growth/

User Image NVDAMillionaire Posted - 4 months ago

$ICCC ImmuCell Corporation (NASDAQ:ICCC): Overcoming Production Challenges to Drive Growth http://beyondspx.com/2024/07/11/immucell-corporation-nasdaqiccc-overcoming-production-challenges-to-drive-growth/

User Image LewisDaKat Posted - 4 months ago

News out $ICCC ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 https://marketwirenews.com/news-releases/immucell-announces-preliminary-unaudited-sales-resul-8382536792531122.html $ICCC

User Image Glopolon Posted - 4 months ago

$ICCC https://seekingalpha.com/pr/19780906-immucell-announces-preliminary-unaudited-sales-results-for-q2-2024 Solid numbers

User Image DonCorleone77 Posted - 4 months ago

$ICCC Immucell reports preliminary Q2 revenue $5.47, one estimate $5.4M ImmuCell announced preliminary, unaudited sales results for the second quarter of 2024, which ended June 30...During the three-, six- and twelve-month periods ended June 30, 2024, annualized production output was approximately 74%, 85% and 77%, respectively, of the Company's estimated full capacity of $30 million per year. As of June 30, 2024, the backlog of orders aggregated approximately $8.93M. "We plan to push our production processes aggressively during the second half of 2024 with the goal of producing an additional $14M worth of product, which would amount to approximately 95% of our estimated full capacity for that period," commented Michael F. Brigham, President and CEO of ImmuCell. "If we are able to achieve this goal, we will have produced approximately 90% of our estimated full capacity for the year and created significant sales growth over the year ended December 31, 2023." "In addition, we continue to work to achieve FDA approval to commercialize Re-Tain Mr. Brigham concluded. "We plan to provide an update when we have made our fourth submission of the CMC Technical Section. We anticipate making this submission shortly after the inspectional observations at our contract manufacturer are resolved to the satisfaction of the FDA, and we expect less than a 180-day review of the CMC by the FDA after that."

User Image Stock_Titan Posted - 4 months ago

$ICCC ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 https://www.stocktitan.net/news/ICCC/immu-cell-announces-preliminary-unaudited-sales-results-for-q2-9zfye3lr9y9r.html

User Image TickerDD_com Posted - 4 months ago

From 6/28/2024, looking back across 21 Month-Ends for ICCC, Percentage Change of Average Monthly Price had More Negatives (59%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ICCC #ICCC #ICCCStock #TickerDD #ICCCPrice https://www.youtube.com/watch?v=NwrDXs3foYY

Analyst Ratings
Aegis Capital Buy Jul 13, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Cunningham David Director Director Jun 13 Buy 8.0000 1,000 8,000 16,000 06/14/22